@inproceedings{inproceedings, title  = {{Pharmacolkinetics (PK) and pharmacodynamics (PD) of AMG 162, a fully human monoclonal antibody to receptor activator of NF kappa B ligand (RANKL), following a single subcutaneous dose to patients with cancer-related bone}},

 url = {{}},

 year = {{2004}},

 month = {{7}},

 author = {{Peterson MC and Martin SW and Stouch B and Chen D and Holloway DL and Body JJ and Lipton A and Coleman R and Bekker PJ}},

 volume = {{22}},

 journal = {{JOURNAL OF CLINICAL ONCOLOGY}},

 issue = {{14}},

 pages = {{755S-755S}},

 note = {{Accessed on 2025/10/10}}}